Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Oncology Biosimilars Market 2018, Forecast to 2023

Choose Licence

 

Oncology biosimilars are similar versions of oncology biologics that are manufactured by different companies and have been officially approved for cancer treatment. Biosimilars are cost-effective molecules with the same efficacy and potency as the original reference biologic. The relatively easy manufacturing of biosimilars and the license to manufacture biosimilars after the expiration of original reference biologic is acting in favor of the global oncology biosimilars market. Scope of the Report: This report focuses on the Oncology Biosimilars in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Cancer represents a massive burden on healthcare systems worldwide due to the high cost of treatment therapeutics. The patent expiry of several cancer therapeutics has allowed the entry of biosimilars, which are being incorporated into oncology treatment practices. Biosimilars are synthesized with the use of biologic components such as monoclonal antibodies, proteins, hormones, nucleic acids, colony stimulating factors, interleukins, and enzymes. The market offers huge growth opportunities for vendors because of the growing incidence of cancer. The clinical pipeline for cancer biosimilars is vast, featuring candidates in different stages of development. Around 30% of all the biosimilars that are awaiting the US FDA?s approval are monoclonal antibodies, including biosimilars of Avastin, MabThera, and Herceptin. Factors like the arrival of new biosimilars to drive market growth during the forecast period. Unlike generic drugs, which have APIs that are identical to original drugs, biosimilars are similar to their originator biologic compounds. Biosimilars developed by different manufacturers differ from the original product as well as from each other. Since they are less expensive than biologics, patients will be able to afford and access biosimilars more easily than biologics. Rise in number of patent expiries, increase in prevalence of cancer, growing aging population, promising drug pipeline, need for cost-effective treatment, favorable government regulations are some of the key drivers promoting the growth of oncology biosimilars market. The worldwide market for Oncology Biosimilars is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study. Market Segment by Manufacturers, this report covers Biocon Celltrion Dr Reddy's Laboratories F Hoffmann-La Roche Mylan Sandoz Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers Breast Cancer Blood Cancer Colorectal Cancer Non-Small Cell Lung Cancer Neutropenia Others Market Segment by Applications, can be divided into Retail Pharmacies Hospitals There are 15 Chapters to deeply display the global Oncology Biosimilars market. Chapter 1, to describe Oncology Biosimilars Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Oncology Biosimilars, with sales, revenue, and price of Oncology Biosimilars, in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Oncology Biosimilars, for each region, from 2013 to 2018; Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions; Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018; Chapter 12, Oncology Biosimilars market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023; Chapter 13, 14 and 15, to describe Oncology Biosimilars sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

 

Table of Contents 1 Market Overview 1.1 Oncology Biosimilars Introduction 1.2 Market Analysis by Type 1.2.1 Breast Cancer 1.2.2 Blood Cancer 1.2.3 Colorectal Cancer 1.2.4 Non-Small 1.2.5 Cell Lung Cancer 1.2.6 Neutropenia 1.2.7 Others 1.3 Market Analysis by Applications 1.3.1 Retail Pharmacies 1.3.2 Hospitals 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2013-2023) 1.4.1.2 Canada Market States and Outlook (2013-2023) 1.4.1.3 Mexico Market States and Outlook (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2013-2023) 1.4.2.2 France Market States and Outlook (2013-2023) 1.4.2.3 UK Market States and Outlook (2013-2023) 1.4.2.4 Russia Market States and Outlook (2013-2023) 1.4.2.5 Italy Market States and Outlook (2013-2023) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2013-2023) 1.4.3.2 Japan Market States and Outlook (2013-2023) 1.4.3.3 Korea Market States and Outlook (2013-2023) 1.4.3.4 India Market States and Outlook (2013-2023) 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2013-2023) 1.4.4.2 Egypt Market States and Outlook (2013-2023) 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023) 1.4.4.4 South Africa Market States and Outlook (2013-2023) 1.4.4.5 Nigeria Market States and Outlook (2013-2023) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Biocon 2.1.1 Business Overview 2.1.1.1 Biocon Description 2.1.1.2 Biocon Headquarter, Main Business and Finance Overview 2.1.2 Biocon Oncology Biosimilars Product Introduction 2.1.2.1 Oncology Biosimilars Production Bases, Sales Regions and Major Competitors 2.1.2.2 Oncology Biosimilars Product Information 2.1.3 Biocon Oncology Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.1.3.1 Biocon Oncology Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.1.3.2 Global Biocon Oncology Biosimilars Market Share in 2017 2.2 Celltrion 2.2.1 Business Overview 2.2.1.1 Celltrion Description 2.2.1.2 Celltrion Headquarter, Main Business and Finance Overview 2.2.2 Celltrion Oncology Biosimilars Product Introduction 2.2.2.1 Oncology Biosimilars Production Bases, Sales Regions and Major Competitors 2.2.2.2 Oncology Biosimilars Product Information 2.2.3 Celltrion Oncology Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2.3.1 Celltrion Oncology Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2.3.2 Global Celltrion Oncology Biosimilars Market Share in 2017 2.3 Dr Reddy's Laboratories 2.3.1 Business Overview 2.3.1.1 Dr Reddy's Laboratories Description 2.3.1.2 Dr Reddy's Laboratories Headquarter, Main Business and Finance Overview 2.3.2 Dr Reddy's Laboratories Oncology Biosimilars Product Introduction 2.3.2.1 Oncology Biosimilars Production Bases, Sales Regions and Major Competitors 2.3.2.2 Oncology Biosimilars Product Information 2.3.3 Dr Reddy's Laboratories Oncology Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3.3.1 Dr Reddy's Laboratories Oncology Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3.3.2 Global Dr Reddy's Laboratories Oncology Biosimilars Market Share in 2017 2.4 F Hoffmann-La Roche 2.4.1 Business Overview 2.4.1.1 F Hoffmann-La Roche Description 2.4.1.2 F Hoffmann-La Roche Headquarter, Main Business and Finance Overview 2.4.2 F Hoffmann-La Roche Oncology Biosimilars Product Introduction 2.4.2.1 Oncology Biosimilars Production Bases, Sales Regions and Major Competitors 2.4.2.2 Oncology Biosimilars Product Information 2.4.3 F Hoffmann-La Roche Oncology Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4.3.1 F Hoffmann-La Roche Oncology Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4.3.2 Global F Hoffmann-La Roche Oncology Biosimilars Market Share in 2017 2.5 Mylan 2.5.1 Business Overview 2.5.1.1 Mylan Description 2.5.1.2 Mylan Headquarter, Main Business and Finance Overview 2.5.2 Mylan Oncology Biosimilars Product Introduction 2.5.2.1 Oncology Biosimilars Production Bases, Sales Regions and Major Competitors 2.5.2.2 Oncology Biosimilars Product Information 2.5.3 Mylan Oncology Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5.3.1 Mylan Oncology Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5.3.2 Global Mylan Oncology Biosimilars Market Share in 2017 2.6 Sandoz 2.6.1 Business Overview 2.6.1.1 Sandoz Description 2.6.1.2 Sandoz Headquarter, Main Business and Finance Overview 2.6.2 Sandoz Oncology Biosimilars Product Introduction 2.6.2.1 Oncology Biosimilars Production Bases, Sales Regions and Major Competitors 2.6.2.2 Oncology Biosimilars Product Information 2.6.3 Sandoz Oncology Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6.3.1 Sandoz Oncology Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6.3.2 Global Sandoz Oncology Biosimilars Market Share in 2017 3 Global Oncology Biosimilars Market Competition, by Manufacturer 3.1 Global Oncology Biosimilars Sales and Market Share by Manufacturer (2016-2017) 3.2 Global Oncology Biosimilars Revenue and Market Share by Manufacturer (2016-2017) 3.3 Global Oncology Biosimilars Price by Manufacturer (2016-2017) 3.4 Market Concentration Rate 3.4.1 Top 3 Oncology Biosimilars Manufacturer Market Share in 2017 3.4.2 Top 5 Oncology Biosimilars Manufacturer Market Share in 2017 3.5 Market Competition Trend 4 Global Oncology Biosimilars Market Analysis by Regions 4.1 Global Oncology Biosimilars Sales, Revenue and Market Share by Regions 4.1.1 Global Oncology Biosimilars Sales by Regions (2013-2018) 4.1.2 Global Oncology Biosimilars Revenue by Regions (2013-2018) 4.2 North America Oncology Biosimilars Sales, Revenue and Growth Rate (2013-2018) 4.3 Europe Oncology Biosimilars Sales, Revenue and Growth Rate (2013-2018) 4.4 Asia-Pacific Oncology Biosimilars Sales, Revenue and Growth Rate (2013-2018) 4.5 South America Oncology Biosimilars Sales, Revenue and Growth Rate (2013-2018) 4.6 Middle East and Africa Oncology Biosimilars Sales, Revenue and Growth Rate (2013-2018) 5 North America Oncology Biosimilars by Countries, Type, Application and Manufacturers 5.1 North America Oncology Biosimilars Sales, Revenue and Market Share by Countries 5.1.1 North America Oncology Biosimilars Sales by Countries (2013-2018) 5.1.2 North America Oncology Biosimilars Revenue by Countries (2013-2018) 5.1.3 United States Oncology Biosimilars Sales and Growth Rate (2013-2018) 5.1.4 Canada Oncology Biosimilars Sales and Growth Rate (2013-2018) 5.1.5 Mexico Oncology Biosimilars Sales and Growth Rate (2013-2018) 5.2 North America Oncology Biosimilars Sales and Revenue (Value) by Manufacturers (2016-2017) 5.2.1 North America Oncology Biosimilars Sales by Manufacturers (2016-2017) 5.2.2 North America Oncology Biosimilars Revenue by Manufacturers (2016-2017) 5.3 North America Oncology Biosimilars Sales, Revenue and Market Share by Type (2013-2018) 5.3.1 North America Oncology Biosimilars Sales and Sales Share by Type (2013-2018) 5.3.2 North America Oncology Biosimilars Revenue and Revenue Share by Type (2013-2018) 5.4 North America Oncology Biosimilars Sales, Revenue and Market Share by Application (2013-2018) 5.4.1 North America Oncology Biosimilars Sales and Sales Share by Application (2013-2018) 5.4.2 North America Oncology Biosimilars Revenue and Revenue Share by Application (2013-2018) 6 Europe Oncology Biosimilars by Countries, Type, Application and Manufacturers 6.1 Europe Oncology Biosimilars Sales, Revenue and Market Share by Countries 6.1.1 Europe Oncology Biosimilars Sales by Countries (2013-2018) 6.1.2 Europe Oncology Biosimilars Revenue by Countries (2013-2018) 6.1.3 Germany Oncology Biosimilars Sales and Growth Rate (2013-2018) 6.1.4 UK Oncology Biosimilars Sales and Growth Rate (2013-2018) 6.1.5 France Oncology Biosimilars Sales and Growth Rate (2013-2018) 6.1.6 Russia Oncology Biosimilars Sales and Growth Rate (2013-2018) 6.1.7 Italy Oncology Biosimilars Sales and Growth Rate (2013-2018) 6.2 Europe Oncology Biosimilars Sales and Revenue (Value) by Manufacturers (2016-2017) 6.2.1 Europe Oncology Biosimilars Sales by Manufacturers (2016-2017) 6.2.2 Europe Oncology Biosimilars Revenue by Manufacturers (2016-2017) 6.3 Europe Oncology Biosimilars Sales, Revenue and Market Share by Type (2013-2018) 6.3.1 Europe Oncology Biosimilars Sales and Sales Share by Type (2013-2018) 6.3.2 Europe Oncology Biosimilars Revenue and Revenue Share by Type (2013-2018) 6.4 Europe Oncology Biosimilars Sales, Revenue and Market Share by Application (2013-2018) 6.4.1 Europe Oncology Biosimilars Sales and Sales Share by Application (2013-2018) 6.4.2 Europe Oncology Biosimilars Revenue and Revenue Share by Application (2013-2018) 7 Asia-Pacific Oncology Biosimilars by Countries, Type, Application and Manufacturers 7.1 Asia-Pacific Oncology Biosimilars Sales, Revenue and Market Share by Countries 7.1.1 Asia-Pacific Oncology Biosimilars Sales by Countries (2013-2018) 7.1.2 Asia-Pacific Oncology Biosimilars Revenue by Countries (2013-2018) 7.1.3 China Oncology Biosimilars Sales and Growth Rate (2013-2018) 7.1.4 Japan Oncology Biosimilars Sales and Growth Rate (2013-2018) 7.1.5 Korea Oncology Biosimilars Sales and Growth Rate (2013-2018) 7.1.6 India Oncology Biosimilars Sales and Growth Rate (2013-2018) 7.1.7 Southeast Asia Oncology Biosimilars Sales and Growth Rate (2013-2018) 7.2 Asia-Pacific Oncology Biosimilars Sales and Revenue (Value) by Manufacturers (2016-2017) 7.2.1 Asia-Pacific Oncology Biosimilars Sales by Manufacturers (2016-2017) 7.2.2 Asia-Pacific Oncology Biosimilars Revenue by Manufacturers (2016-2017) 7.3 Asia-Pacific Oncology Biosimilars Sales, Revenue and Market Share by Type (2013-2018) 7.3.1 Asia-Pacific Oncology Biosimilars Sales and Sales Share by Type (2013-2018) 7.3.2 Asia-Pacific Oncology Biosimilars Revenue and Revenue Share by Type (2013-2018) 7.4 Asia-Pacific Oncology Biosimilars Sales, Revenue and Market Share by Application (2013-2018) 7.4.1 Asia-Pacific Oncology Biosimilars Sales and Sales Share by Application (2013-2018) 7.4.2 Asia-Pacific Oncology Biosimilars Revenue and Revenue Share by Application (2013-2018) 8 South America Oncology Biosimilars by Countries, Type, Application and Manufacturers 8.1 South America Oncology Biosimilars Sales, Revenue and Market Share by Countries 8.1.1 South America Oncology Biosimilars Sales by Countries (2013-2018) 8.1.2 South America Oncology Biosimilars Revenue by Countries (2013-2018) 8.1.3 Brazil Oncology Biosimilars Sales and Growth Rate (2013-2018) 8.1.4 Argentina Oncology Biosimilars Sales and Growth Rate (2013-2018) 8.1.5 Colombia Oncology Biosimilars Sales and Growth Rate (2013-2018) 8.2 South America Oncology Biosimilars Sales and Revenue (Value) by Manufacturers (2016-2017) 8.2.1 South America Oncology Biosimilars Sales by Manufacturers (2016-2017) 8.2.2 South America Oncology Biosimilars Revenue by Manufacturers (2016-2017) 8.3 South America Oncology Biosimilars Sales, Revenue and Market Share by Type (2013-2018) 8.3.1 South America Oncology Biosimilars Sales and Sales Share by Type (2013-2018) 8.3.2 South America Oncology Biosimilars Revenue and Revenue Share by Type (2013-2018) 8.4 South America Oncology Biosimilars Sales, Revenue and Market Share by Application (2013-2018) 8.4.1 South America Oncology Biosimilars Sales and Sales Share by Application (2013-2018) 8.4.2 South America Oncology Biosimilars Revenue and Revenue Share by Application (2013-2018) 9 Middle East and Africa Oncology Biosimilars by Countries, Type, Application and Manufacturers 9.1 Middle East and Africa Oncology Biosimilars Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Oncology Biosimilars Sales by Countries (2013-2018) 9.1.2 Middle East and Africa Oncology Biosimilars Revenue by Countries (2013-2018) 9.1.3 Saudi Arabia Oncology Biosimilars Sales and Growth Rate (2013-2018) 9.1.4 UAE Oncology Biosimilars Sales and Growth Rate (2013-2018) 9.1.5 Egypt Oncology Biosimilars Sales and Growth Rate (2013-2018) 9.1.6 Nigeria Oncology Biosimilars Sales and Growth Rate (2013-2018) 9.1.7 South Africa Oncology Biosimilars Sales and Growth Rate (2013-2018) 9.2 Middle East and Africa Oncology Biosimilars Sales and Revenue (Value) by Manufacturers (2016-2017) 9.2.1 Middle East and Africa Oncology Biosimilars Sales by Manufacturers (2016-2017) 9.2.2 Middle East and Africa Oncology Biosimilars Revenue by Manufacturers (2016-2017) 9.3 Middle East and Africa Oncology Biosimilars Sales, Revenue and Market Share by Type (2013-2018) 9.3.1 Middle East and Africa Oncology Biosimilars Sales and Sales Share by Type (2013-2018) 9.3.1 Middle East and Africa Oncology Biosimilars Revenue and Revenue Share by Type (2013-2018) 9.4 Middle East and Africa Oncology Biosimilars Sales, Revenue and Market Share by Application (2013-2018) 9.4.1 Middle East and Africa Oncology Biosimilars Sales and Sales Share by Application (2013-2018) 9.4.2 Middle East and Africa Oncology Biosimilars Revenue and Revenue Share by Application (2013-2018) 10 Global Oncology Biosimilars Market Segment by Type 10.1 Global Oncology Biosimilars Sales, Revenue and Market Share by Type (2013-2018) 10.1.1 Global Oncology Biosimilars Sales and Market Share by Type (2013-2018) 10.1.2 Global Oncology Biosimilars Revenue and Market Share by Type (2013-2018) 10.2 Breast Cancer Sales Growth and Price 10.2.1 Global Breast Cancer Sales Growth (2013-2018) 10.2.2 Global Breast Cancer Price (2013-2018) 10.3 Blood Cancer Sales Growth and Price 10.3.1 Global Blood Cancer Sales Growth (2013-2018) 10.3.2 Global Blood Cancer Price (2013-2018) 10.4 Colorectal Cancer Sales Growth and Price 10.4.1 Global Colorectal Cancer Sales Growth (2013-2018) 10.4.2 Global Colorectal Cancer Price (2013-2018) 10.5 Non-Small Sales Growth and Price 10.5.1 Global Non-Small Sales Growth (2013-2018) 10.5.2 Global Non-Small Price (2013-2018) 10.6 Cell Lung Cancer Sales Growth and Price 10.6.1 Global Cell Lung Cancer Sales Growth (2013-2018) 10.6.2 Global Cell Lung Cancer Price (2013-2018) 10.7 Neutropenia Sales Growth and Price 10.7.1 Global Neutropenia Sales Growth (2013-2018) 10.7.2 Global Neutropenia Price (2013-2018) 10.8 Others Sales Growth and Price 10.8.1 Global Others Sales Growth (2013-2018) 10.8.2 Global Others Price (2013-2018) 11 Global Oncology Biosimilars Market Segment by Application 11.1 Global Oncology Biosimilars Sales Market Share by Application (2013-2018) 11.2 Retail Pharmacies Sales Growth (2013-2018) 11.3 Hospitals Sales Growth (2013-2018) 12 Oncology Biosimilars Market Forecast (2018-2023) 12.1 Global Oncology Biosimilars Sales, Revenue and Growth Rate (2018-2023) 12.2 Oncology Biosimilars Market Forecast by Regions (2018-2023) 12.2.1 North America Oncology Biosimilars Market Forecast (2018-2023) 12.2.2 Europe Oncology Biosimilars Market Forecast (2018-2023) 12.2.3 Asia-Pacific Oncology Biosimilars Market Forecast (2018-2023) 12.2.4 South America Oncology Biosimilars Market Forecast (2018-2023) 12.2.5 Middle East and Africa Oncology Biosimilars Market Forecast (2018-2023) 12.3 Oncology Biosimilars Market Forecast by Type (2018-2023) 12.3.1 Global Oncology Biosimilars Sales Forecast by Type (2018-2023) 12.3.2 Global Oncology Biosimilars Market Share Forecast by Type (2018-2023) 12.4 Oncology Biosimilars Market Forecast by Application (2018-2023) 12.4.1 Global Oncology Biosimilars Sales Forecast by Application (2018-2023) 12.4.2 Global Oncology Biosimilars Market Share Forecast by Application (2018-2023) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source

List of Tables and Figures Figure Oncology Biosimilars Picture Table Product Specifications of Oncology Biosimilars Figure Global Oncology Biosimilars CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 ( Million) Figure Global Oncology Biosimilars CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales) Figure Global Sales Market Share of Oncology Biosimilars by Types in 2017 Figure Breast Cancer Picture Table Major Manufacturers of Breast Cancer Figure Blood Cancer Picture Table Major Manufacturers of Blood Cancer Figure Colorectal Cancer Picture Table Major Manufacturers of Colorectal Cancer Figure Non-Small Picture Table Major Manufacturers of Non-Small Figure Cell Lung Cancer Picture Table Major Manufacturers of Cell Lung Cancer Figure Neutropenia Picture Table Major Manufacturers of Neutropenia Figure Others Picture Table Major Manufacturers of Others Figure Oncology Biosimilars Sales Market Share by Applications in 2017 Figure Retail Pharmacies Picture Figure Hospitals Picture Figure United States Oncology Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure Canada Oncology Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure Mexico Oncology Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure Germany Oncology Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure France Oncology Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure UK Oncology Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure Russia Oncology Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure Italy Oncology Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure China Oncology Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure Japan Oncology Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure Korea Oncology Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure India Oncology Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure Southeast Asia Oncology Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure Brazil Oncology Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure Egypt Oncology Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure Saudi Arabia Oncology Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure South Africa Oncology Biosimilars Revenue (Value) and Growth Rate (2013-2023) Figure Nigeria Oncology Biosimilars Revenue (Value) and Growth Rate (2013-2023) Table Biocon Headquarter, Established, Main Business and Finance Overview (2017) Table Biocon Oncology Biosimilars Production Bases, Sales Regions and Major Competitors Table Biocon Oncology Biosimilars Product Table Biocon Oncology Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Figure Global Biocon Oncology Biosimilars Sales Market Share in 2017 Figure Global Biocon Oncology Biosimilars Revenue Market Share in 2017 Table Celltrion Headquarter, Established, Main Business and Finance Overview (2017) Table Celltrion Oncology Biosimilars Production Bases, Sales Regions and Major Competitors Table Celltrion Oncology Biosimilars Product Table Celltrion Oncology Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Figure Global Celltrion Oncology Biosimilars Sales Market Share in 2017 Figure Global Celltrion Oncology Biosimilars Revenue Market Share in 2017 Table Dr Reddy's Laboratories Headquarter, Established, Main Business and Finance Overview (2017) Table Dr Reddy's Laboratories Oncology Biosimilars Production Bases, Sales Regions and Major Competitors Table Dr Reddy's Laboratories Oncology Biosimilars Product Table Dr Reddy's Laboratories Oncology Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Figure Global Dr Reddy's Laboratories Oncology Biosimilars Sales Market Share in 2017 Figure Global Dr Reddy's Laboratories Oncology Biosimilars Revenue Market Share in 2017 Table F Hoffmann-La Roche Headquarter, Established, Main Business and Finance Overview (2017) Table F Hoffmann-La Roche Oncology Biosimilars Production Bases, Sales Regions and Major Competitors Table F Hoffmann-La Roche Oncology Biosimilars Product Table F Hoffmann-La Roche Oncology Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Figure Global F Hoffmann-La Roche Oncology Biosimilars Sales Market Share in 2017 Figure Global F Hoffmann-La Roche Oncology Biosimilars Revenue Market Share in 2017 Table Mylan Headquarter, Established, Main Business and Finance Overview (2017) Table Mylan Oncology Biosimilars Production Bases, Sales Regions and Major Competitors Table Mylan Oncology Biosimilars Product Table Mylan Oncology Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Figure Global Mylan Oncology Biosimilars Sales Market Share in 2017 Figure Global Mylan Oncology Biosimilars Revenue Market Share in 2017 Table Sandoz Headquarter, Established, Main Business and Finance Overview (2017) Table Sandoz Oncology Biosimilars Production Bases, Sales Regions and Major Competitors Table Sandoz Oncology Biosimilars Product Table Sandoz Oncology Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Figure Global Sandoz Oncology Biosimilars Sales Market Share in 2017 Figure Global Sandoz Oncology Biosimilars Revenue Market Share in 2017 Table Global Oncology Biosimilars Sales by Manufacturer (2016-2017) Figure Global Oncology Biosimilars Sales Market Share by Manufacturer in 2016 Figure Global Oncology Biosimilars Sales Market Share by Manufacturer in 2017 Table Global Oncology Biosimilars Revenue by Manufacturer (2016-2017) Figure Global Oncology Biosimilars Revenue Market Share by Manufacturer in 2016 Figure Global Oncology Biosimilars Revenue Market Share by Manufacturer in 2017 Table Global Oncology Biosimilars Price by Manufacturer (2016-2017) Figure Top 3 Oncology Biosimilars Manufacturer (Revenue) Market Share in 2017 Figure Top 6 Oncology Biosimilars Manufacturer (Revenue) Market Share in 2017 Figure Global Oncology Biosimilars Sales and Growth Rate (2013-2018) Figure Global Oncology Biosimilars Revenue and Growth Rate (2013-2018) Table Global Oncology Biosimilars Sales by Regions (2013-2018) Table Global Oncology Biosimilars Sales Market Share by Regions (2013-2018) Table Global Oncology Biosimilars Revenue by Regions (2013-2018) Figure Global Oncology Biosimilars Revenue Market Share by Regions in 2013 Figure Global Oncology Biosimilars Revenue Market Share by Regions in 2017 Figure North America Oncology Biosimilars Sales and Growth Rate (2013-2018) Figure North America Oncology Biosimilars Revenue and Growth Rate (2013-2018) Figure Europe Oncology Biosimilars Sales and Growth Rate (2013-2018) Figure Europe Oncology Biosimilars Revenue and Growth Rate (2013-2018) Figure Asia-Pacific Oncology Biosimilars Sales and Growth Rate (2013-2018) Figure Asia-Pacific Oncology Biosimilars Revenue and Growth Rate (2013-2018) Figure South America Oncology Biosimilars Sales and Growth Rate (2013-2018) Figure South America Oncology Biosimilars Revenue and Growth Rate (2013-2018) Figure Middle East and Africa Oncology Biosimilars Sales and Growth Rate (2013-2018) Figure Middle East and Africa Oncology Biosimilars Revenue and Growth Rate (2013-2018) Figure North America Oncology Biosimilars Revenue and Growth Rate (2013-2018) Table North America Oncology Biosimilars Sales by Countries (2013-2018) Table North America Oncology Biosimilars Sales Market Share by Countries (2013-2018) Figure North America Oncology Biosimilars Sales Market Share by Countries in 2013 Figure North America Oncology Biosimilars Sales Market Share by Countries in 2017 Table North America Oncology Biosimilars Revenue by Countries (2013-2018) Table North America Oncology Biosimilars Revenue Market Share by Countries (2013-2018) Figure North America Oncology Biosimilars Revenue Market Share by Countries in 2013 Figure North America Oncology Biosimilars Revenue Market Share by Countries in 2017 Figure United States Oncology Biosimilars Sales and Growth Rate (2013-2018) Figure Canada Oncology Biosimilars Sales and Growth Rate (2013-2018) Figure Mexico Oncology Biosimilars Sales and Growth Rate (2013-2018) Table North America Oncology Biosimilars Sales by Manufacturer (2016-2017) Figure North America Oncology Biosimilars Sales Market Share by Manufacturer in 2016 Figure North America Oncology Biosimilars Sales Market Share by Manufacturer in 2017 Table North America Oncology Biosimilars Revenue by Manufacturer (2016-2017) Figure North America Oncology Biosimilars Revenue Market Share by Manufacturer in 2016 Figure North America Oncology Biosimilars Revenue Market Share by Manufacturer in 2017 Table North America Oncology Biosimilars Sales by Type (2013-2018) Table North America Oncology Biosimilars Sales Share by Type (2013-2018) Table North America Oncology Biosimilars Revenue by Type (2013-2018) Table North America Oncology Biosimilars Revenue Share by Type (2013-2018) Table North America Oncology Biosimilars Sales by Application (2013-2018) Table North America Oncology Biosimilars Sales Share by Application (2013-2018) Table North America Oncology Biosimilars Revenue by Application (2013-2018) Table North America Oncology Biosimilars Revenue Share by Application (2013-2018) Figure Europe Oncology Biosimilars Revenue and Growth Rate (2013-2018) Table Europe Oncology Biosimilars Sales by Countries (2013-2018) Table Europe Oncology Biosimilars Sales Market Share by Countries (2013-2018) Table Europe Oncology Biosimilars Revenue by Countries (2013-2018) Figure Europe Oncology Biosimilars Revenue Market Share by Countries in 2016 Figure Europe Oncology Biosimilars Revenue Market Share by Countries in 2017 Figure Germany Oncology Biosimilars Sales and Growth Rate (2013-2018) Figure UK Oncology Biosimilars Sales and Growth Rate (2013-2018) Figure France Oncology Biosimilars Sales and Growth Rate (2013-2018) Figure Russia Oncology Biosimilars Sales and Growth Rate (2013-2018) Figure Italy Oncology Biosimilars Sales and Growth Rate (2013-2018) Table Europe Oncology Biosimilars Sales by Manufacturer (2016-2017) Figure Europe Oncology Biosimilars Sales Market Share by Manufacturer in 2016 Figure Europe Oncology Biosimilars Sales Market Share by Manufacturer in 2017 Table Europe Oncology Biosimilars Revenue by Manufacturer (2016-2017) Figure Europe Oncology Biosimilars Revenue Market Share by Manufacturer in 2016 Figure Europe Oncology Biosimilars Revenue Market Share by Manufacturer in 2017 Table Europe Oncology Biosimilars Sales by Type (2013-2018) Table Europe Oncology Biosimilars Sales Share by Type (2013-2018) Table Europe Oncology Biosimilars Revenue by Type (2013-2018) Table Europe Oncology Biosimilars Revenue Share by Type (2013-2018) Table Europe Oncology Biosimilars Sales by Application (2013-2018) Table Europe Oncology Biosimilars Sales Share by Application (2013-2018) Table Europe Oncology Biosimilars Revenue by Application (2013-2018) Table Europe Oncology Biosimilars Revenue Share by Application (2013-2018) Figure Asia-Pacific Oncology Biosimilars Revenue and Growth Rate (2013-2018) Table Asia-Pacific Oncology Biosimilars Sales by Countries (2013-2018) Table Asia-Pacific Oncology Biosimilars Sales Market Share by Countries (2013-2018) Figure Asia-Pacific Oncology Biosimilars Sales Market Share by Countries 2017 Table Asia-Pacific Oncology Biosimilars Revenue by Countries (2013-2018) Figure Asia-Pacific Oncology Biosimilars Revenue Market Share by Countries 2017 Figure China Oncology Biosimilars Sales and Growth Rate (2013-2018) Figure Japan Oncology Biosimilars Sales and Growth Rate (2013-2018) Figure Korea Oncology Biosimilars Sales and Growth Rate (2013-2018) Figure India Oncology Biosimilars Sales and Growth Rate (2013-2018) Figure Southeast Asia Oncology Biosimilars Sales and Growth Rate (2013-2018) Table Asia-Pacific Oncology Biosimilars Sales by Manufacturer (2016-2017) Figure Asia-Pacific Oncology Biosimilars Sales Market Share by Manufacturer in 2016 Figure Asia-Pacific Oncology Biosimilars Sales Market Share by Manufacturer in 2017 Table Asia-Pacific Oncology Biosimilars Revenue by Manufacturer (2016-2017) Figure Asia-Pacific Oncology Biosimilars Revenue Market Share by Manufacturer in 2016 Figure Asia-Pacific Oncology Biosimilars Revenue Market Share by Manufacturer in 2017 Table Asia-Pacific Oncology Biosimilars Sales by Type (2013-2018) Table Asia-Pacific Oncology Biosimilars Sales Share by Type (2013-2018) Table Asia-Pacific Oncology Biosimilars Revenue by Type (2013-2018) Table Asia-Pacific Oncology Biosimilars Revenue Share by Type (2013-2018) Table Asia-Pacific Oncology Biosimilars Sales by Application (2013-2018) Table Asia-Pacific Oncology Biosimilars Sales Share by Application (2013-2018) Table Asia-Pacific Oncology Biosimilars Revenue by Application (2013-2018) Table Asia-Pacific Oncology Biosimilars Revenue Share by Application (2013-2018) Figure South America Oncology Biosimilars Revenue and Growth Rate (2013-2018) Table South America Oncology Biosimilars Sales by Countries (2013-2018) Table South America Oncology Biosimilars Sales Market Share by Countries (2013-2018) Figure South America Oncology Biosimilars Sales Market Share by Countries in 2017 Table South America Oncology Biosimilars Revenue by Countries (2013-2018) Table South America Oncology Biosimilars Revenue Market Share by Countries (2013-2018) Figure South America Oncology Biosimilars Revenue Market Share by Countries in 2017 Figure Brazil Oncology Biosimilars Sales and Growth Rate (2013-2018) Figure Argentina Oncology Biosimilars Sales and Growth Rate (2013-2018) Figure Colombia Oncology Biosimilars Sales and Growth Rate (2013-2018) Table South America Oncology Biosimilars Sales by Manufacturer (2016-2017) Figure South America Oncology Biosimilars Sales Market Share by Manufacturer in 2016 Figure South America Oncology Biosimilars Sales Market Share by Manufacturer in 2017 Table South America Oncology Biosimilars Revenue by Manufacturer (2016-2017) Figure South America Oncology Biosimilars Revenue Market Share by Manufacturer in 2016 Figure South America Oncology Biosimilars Revenue Market Share by Manufacturer in 2017 Table South America Oncology Biosimilars Sales by Type (2013-2018) Table South America Oncology Biosimilars Sales Share by Type (2013-2018) Table South America Oncology Biosimilars Revenue by Type (2013-2018) Table South America Oncology Biosimilars Revenue Share by Type (2013-2018) Table South America Oncology Biosimilars Sales by Application (2013-2018) Table South America Oncology Biosimilars Sales Share by Application (2013-2018) Table South America Oncology Biosimilars Revenue by Application (2013-2018) Table South America Oncology Biosimilars Revenue Share by Application (2013-2018) Figure Middle East and Africa Oncology Biosimilars Revenue and Growth Rate (2013-2018) Table Middle East and Africa Oncology Biosimilars Sales by Countries (2013-2018) Table Middle East and Africa Oncology Biosimilars Sales Market Share by Countries (2013-2018) Figure Middle East and Africa Oncology Biosimilars Sales Market Share by Countries in 2017 Table Middle East and Africa Oncology Biosimilars Revenue by Countries (2013-2018) Table Middle East and Africa Oncology Biosimilars Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Oncology Biosimilars Revenue Market Share by Countries in 2013 Figure Middle East and Africa Oncology Biosimilars Revenue Market Share by Countries in 2017 Figure Saudi Arabia Oncology Biosimilars Sales and Growth Rate (2013-2018) Figure UAE Oncology Biosimilars Sales and Growth Rate (2013-2018) Figure Egypt Oncology Biosimilars Sales and Growth Rate (2013-2018) Figure Nigeria Oncology Biosimilars Sales and Growth Rate (2013-2018) Figure South Africa Oncology Biosimilars Sales and Growth Rate (2013-2018) Table Middle East and Africa Oncology Biosimilars Sales by Manufacturer (2016-2017) Figure Middle East and Africa Oncology Biosimilars Sales Market Share by Manufacturer in 2016 Figure Middle East and Africa Oncology Biosimilars Sales Market Share by Manufacturer in 2017 Table Middle East and Africa Oncology Biosimilars Revenue by Manufacturer (2016-2017) Figure Middle East and Africa Oncology Biosimilars Revenue Market Share by Manufacturer in 2016 Figure Middle East and Africa Oncology Biosimilars Revenue Market Share by Manufacturer in 2017 Table Middle East and Africa Oncology Biosimilars Sales by Type (2013-2018) Table Middle East and Africa Oncology Biosimilars Sales Share by Type (2013-2018) Table Middle East and Africa Oncology Biosimilars Revenue by Type (2013-2018) Table Middle East and Africa Oncology Biosimilars Revenue Share by Type (2013-2018) Table Middle East and Africa Oncology Biosimilars Sales by Application (2013-2018) Table Middle East and Africa Oncology Biosimilars Sales Share by Application (2013-2018) Table Middle East and Africa Oncology Biosimilars Revenue by Application (2013-2018) Table Middle East and Africa Oncology Biosimilars Revenue Share by Application (2013-2018) Table Global Oncology Biosimilars Sales by Type (2013-2018) Table Global Oncology Biosimilars Sales Share by Type (2013-2018) Table Global Oncology Biosimilars Revenue by Type (2013-2018) Table Global Oncology Biosimilars Revenue Share by Type (2013-2018) Figure Global Breast Cancer Sales Growth (2013-2018) Figure Global Breast Cancer Price (2013-2018) Figure Global Blood Cancer Sales Growth (2013-2018) Figure Global Blood Cancer Price (2013-2018) Figure Global Colorectal Cancer Sales Growth (2013-2018) Figure Global Colorectal Cancer Price (2013-2018) Figure Global Non-Small Sales Growth (2013-2018) Figure Global Non-Small Price (2013-2018) Figure Global Cell Lung Cancer Sales Growth (2013-2018) Figure Global Cell Lung Cancer Price (2013-2018) Figure Global Neutropenia Sales Growth (2013-2018) Figure Global Neutropenia Price (2013-2018) Figure Global Others Sales Growth (2013-2018) Figure Global Others Price (2013-2018) Table Global Oncology Biosimilars Sales by Application (2013-2018) Table Global Oncology Biosimilars Sales Share by Application (2013-2018) Figure Global Retail Pharmacies Sales Growth (2013-2018) Figure Global Hospitals Sales Growth (2013-2018) Figure Global Oncology Biosimilars Sales, Revenue and Growth Rate (2018-2023) Table Global Oncology Biosimilars Sales Forecast by Regions (2018-2023) Table Global Oncology Biosimilars Market Share Forecast by Regions (2018-2023) Figure North America Sales Oncology Biosimilars Market Forecast (2018-2023) Figure Europe Sales Oncology Biosimilars Market Forecast (2018-2023) Figure Asia-Pacific Sales Oncology Biosimilars Market Forecast (2018-2023) Figure South America Sales Oncology Biosimilars Market Forecast (2018-2023) Figure Middle East and Africa Sales Oncology Biosimilars Market Forecast (2018-2023) Table Global Oncology Biosimilars Sales Forecast by Type (2018-2023) Table Global Oncology Biosimilars Market Share Forecast by Type (2018-2023) Table Global Oncology Biosimilars Sales Forecast by Application (2018-2023) Table Global Oncology Biosimilars Market Share Forecast by Application (2018-2023) Table Distributors/Traders/ Dealers List

Qualitative Analysis covers:

  • Industry Status and Trends
  • Manufacturer/Company profiles, manufacturing base distribution, sales areas, product introduction, main business, market position and their competitors.
  • Product Development, Technology, Price, Cost, Manufacturing Process and Trends
  • Market segment by regions, types, applications and forecast
  • Market opportunities, potential, government policies and influence factors.
     

Quantitative Analysis covers:

  • Market size (value, sales/output, historical data and forecasts)
  • Sales/output/capacity, revenue, price, gross margin, market share, for top players. Through interviewing each manufacturers,  distributors, traders, dealers and buyers etc.
  • Cost structure, proportion, price trend, gross margin and trend, status and trend, for 10 years
  • Market size by types, regions, applications for 10 years
  • Market forecast based on the potential demand from downstream clients/buyers, government, influence factors and the total economic indication, maybe occur in following years.
     

Data Sources:

Methodology

 

Other Reports by GlobalInfoResearch

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Photoresist Market 2018, Forecast to 2023

A photoresist is a light-sensitive material used in several processes, such as photolithography and photoengraving, to form a patterned coating on a surface. This process is crucial in the electronic industry.[1] The process begins by coating a subst...

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Phosphate Market 2018, Forecast to 2023

A phosphate is chemical derivative of phosphoric acid. The phosphate ion is an inorganic chemical, the conjugate base that can form many different salts. In organic chemistry, a phosphate, or organophosphate, is an ester of phosphoric acid. Of the va...

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Phenolic Resin Market 2018, Forecast to 2023

Phenolic resins or phenol formaldehyde resins or 2-methoxy-6-methylphenol are synthetic polymers that are obtained by the polymerization of formaldehyde and phenol. These are resistant to acids, water, and organic solvents. These are used especially ...

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Phenol Derivatives Market 2018, Forecast to 2023

In organic chemistry, phenols, sometimes called phenolics, are a class of chemical compounds consisting of a hydroxyl group (?OH) bonded directly to an aromatic hydrocarbon group. Phenolic compounds are classified as simple phenols or polyphenols bas...

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Phase Change Materials (PCM) Market 2018, Forecast to 2023

Phase change materials (PCMs) are substances with a high enthalpy of fusion, also known as latent heat, meaning they can store large quantities of heat energy as they change phase. When melting, they absorb heat and maintain the temperature of the en...

New Pharmaceuticals and Healthcare Reports